October 23, 20252025 Annual Shareholders Meeting ScheduledThe Company has scheduled its 2025 Annual General and Special Meeting for November 13, 2025.Read more
July 10, 2025Moss Genomics Advances Blockchain Integration StrategyThe Company has contributed 200 ETH with a commitment to contribute an additional 800 ETH to the presale of STRAT, an on-chain smart contract that enables ETH-based capital flows through algorithmic expansion and redemption mechanisms...Read more
June 19, 2025Moss Genomics Announces Strategic Investment in Genomes.ioMoss Genomics Inc. announces that it has entered into a non-binding term sheet for a strategic, non-controlling equity investment in Genomes.io...Read more
February 3, 2025Moss Genomics Announces Private Placement and Agreement to Acquire EthereumMoss Genomics Inc. announces a non-brokered private placement of up to 2,000,000 common shares at price of $0.18 per share for aggregate proceeds of up to $360,000...Read more
January 24, 2025Moss Genomics Provides Corporate Update and Announces Shift in Business StrategyMoss Genomics Inc. (CSE: MOSS) (FSE: F73) is pleased to provide an update on the Company's operations and business strategy...Read more
January 14, 2025Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)Moss Genomics Inc. (CSE: MOSS) (FSE: F73) is pleased to announce that it has successfully listed its shares on the Frankfurt Stock Exchange (FSE) under the ticker symbol F73...Read more
December 24, 2024Canadian Company Moss Genomics Announces Agreement to Acquire Ethereum, Appoints Jack Liu as CEOMoss Genomics Inc. announces agreement to acquire 160 ETH and appoints Jack Liu as CEO and Director, marking a significant strategic shift...Read more